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Introduction
In 2018, approximately 41 million children under the age of 
five years were classified as having overweight or obesity1. 
Child obesity prevention is a public health priority, with early 
life intervention advocated2. Effective, scalable, and afford-
able strategies that do not widen health inequities are needed 
to address this issue3,4. In addition, interventions that can be 
embedded into ongoing practice and existing systems are 
required, rather than implementing interventions that are 
resource-intensive and cannot be maintained in the long-term5,6. 
This was echoed in a recent research prioritisation study in 
which ‘Implementation science’ and ‘How to integrate obes-
ity prevention into existing service structures’ were the third 
and fourth ranked research priorities identified by researchers, 
policymakers and practitioners7. To date, there has been limited 
scale-up of childhood obesity prevention interventions.
Appraising scalability prior to investment is vital8,9. Scalabil-
ity is defined by the World Health Organization as ‘the deliber-
ate effort to increase the impact of successfully tested health 
interventions so as to benefit more people and to foster policy 
and program development on a lasting basis’10. An understand-
ing of the external validity of the intervention is critical to 
determining scalability, in addition to understanding the fit 
between an intervention and the political and strategic context. 
External validity refers to the generalizability of the results of 
an intervention to or across target populations or settings, while 
applicability refers to generalizability to any populations or 
settings11. To understand the external validity of an interven-
tion, decision makers need to have sufficient information on the 
reach and acceptability of the intervention, core intervention 
components required for fidelity, any differential effects on the 
target population, unintended consequences, costs versus ben-
efits, and the clinical or policy significance of the intervention 
effects to inform decisions about whether interventions should 
be scaled-up12–16. The poor reporting of external validity ele-
ments in childhood obesity prevention research also limits 
decision-makers’ ability to determine the likely scalability of 
these interventions, limiting the implementation of effective 
interventions into routine practice17,18.
As public health interventions are usually complex, and con-
text dependent, it can be difficult to assess their generalisability 
to other contexts14. There are many tools for assessing generalis-
ability, however, there is no consensus on which should be used, 
or when14. Indeed, Burchett and colleagues argue that such tools 
may not be the best method for generalisability assessments, 
instead advocating a focus on mechanisms of action through 
which an intervention exerts its effect – and which contex-
tual elements underpin them, rather than solely on intervention 
characteristics14. To improve reporting across behavioural inter-
ventions and enhance the translation of research into practice, 
Glasgow and colleagues developed the RE-AIM (Reach, Effec-
tiveness, Adoption, Implementation, Maintenance) framework19,20. 
Reach is the number, proportion of the intended target popu-
lation, and the representativeness of participants compared 
with the intended target population. Effectiveness (or efficacy, 
depending on the study design) is the degree to which the 
intervention changes behavioural, quality of life, and partici-
pant satisfaction outcomes as well as physiologic endpoints, and 
includes attention to positive, unintended and negative results. 
Adoption is the number and proportion of settings and staff 
members that agree to initiate an intervention and how repre-
sentative they are of the target setting and staff. Implementation 
is the degree to which settings and staff members deliver an 
intervention as intended, the adaptations made, and the related 
costs. Finally, maintenance is sustained effectiveness at the 
participant level and sustained (or adapted) delivery at the 
setting or staff level. At the individual level, it refers to the 
long-term results of intervention (defined as a minimum of six 
months following the last contact)20–22. RE-AIM is the most 
frequently applied framework in the translation of research 
evidence into policy and practice23. It has been used to assess 
reports of external validity factors across a variety of areas, 
including weight loss maintenance interventions24, behavioural 
interventions that target physical activity25, mobile health 
physical activity promotion interventions26, physical activity pro-
motion in Latin American populations27, behavioural interven-
tion studies conducted in community settings28, school health 
promotion studies29, behaviour change interventions in healthcare 
settings30, and housing improvement31.
Based on the RE-AIM framework, Green and Glasgow pro-
posed a set of ratings to assess external validity21. These were 
further adapted by Laws and colleagues32 and have been used 
to assess external validity in diabetes prevention research32 
and obesity prevention in children aged 0–5 years18.
Reviews of external validity reporting in childhood obesity 
interventions identify insufficient reporting of elements neces-
sary to make decisions about generalisability17,18. A review of 
            Amendments from Version 1
We have clarified terminology to focus on “evaluating external 
validity reporting” and have defined what we mean by “first 
1,000 days” in the abstract and introduction. More context to 
early childhood obesity prevention has been provided in the 
introduction, and we have clarified the definition of external 
validity, and trial generalisability. We have moved details of the 
external validity assessment tool used from the introduction to 
the methods section. We have added information on inter-rater 
reliability, using percent agreement, to the results section. In 
the discussion, we have noted that researchers could also use 
models such as RE-AIM to guide reporting of external validity 
elements, and that using RE-AIM as a planning tool when 
designing interventions and evaluation might also overcome 
some of the difficulties in reporting on RE-AIM components 
relevant to external validity. While we are not aware of any 
evidence regarding which of the elements of external validity 
are most important/useful, we have noted elements included 
in a recently published tool on assessment of scalability and 
have suggested these be prioritized by researchers in planning 
studies and reporting findings. We have also discussed whether 
efficacy trials should be held to the same standard of such 
reporting as effectiveness trials, given that the latter are intended 
to provide more externally valid findings. We argue that such 
information is important regardless of trial type, not only to inform 
generalisability, but also to enhance understanding of the active 
ingredients of interventions and core components to retain in 
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external validity reporting in 19 long-term follow-up childhood 
obesity prevention trials (children aged 0–18 years) published 
between 1980 and 2004 found that all studies lacked full report-
ing on potential generalizability and dissemination elements; 
the most infrequent were reports of setting level inclusion 
and exclusion criteria and representativeness, characteristics 
regarding intervention staff, implementation of intervention 
content, costs, and program sustainability17. A more recent 
review of external validity reporting in 32 trials of interventions 
to prevent obesity or improve obesity related behaviours in chil-
dren aged 0–5 years from socioeconomically disadvantaged 
or Indigenous families found similar issues with reporting18. 
Health professional-delivered interventions to prevent child-
hood obesity during the first 1,000 days of life (i.e. the period 
from conception to a child’s second birthday) have limited 
impacts on adiposity/weight outcomes, but have more posi-
tive impacts on behavioural outcomes33. Despite the increasing 
numbers of trials to assess the impact of early life obesity 
prevention interventions, there is relatively little reporting 
on the potential for these interventions to be translated into 
routine practice. Furthermore, there is little evidence that inter-
ventions with demonstrated efficacy have been translated beyond 
the research setting and been broadly adopted. Given that it 
can take up to 17 years to translate evidence into practice34, 
it is important to assess the extent to which trials report on fac-
tors that can provide additional explanation for variability in 
intervention outcomes, insights into successful adaptations of 
interventions, inform generalizability across settings and 
populations, and help guide policy decisions.
This study aims to determine the extent to which child-
hood obesity interventions delivered by health professionals 
during the first 1,000 days report on factors that can be used 
inform generalizability across settings and populations, and to 
provide recommendations for researchers planning to conduct 
similar studies.
Methods
We conducted a systematic review of obesity prevention inter-
ventions delivered by health professionals targeting chil-
dren in the first 1,000 days of life. A separate paper reports 
on the effectiveness of such interventions and what behav-
iour change theories and/or techniques are associated with 
more effective intervention outcomes33. The review protocol 
was registered with the International Prospective Register for 
Systematic Reviews (PROSPERO) CRD42016050793 on 3rd 
November 2016. This paper adheres to the PRISMA (Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses) 
standardised reporting guidelines35; the PRISMA checklist is 
available on OSF36.
Search strategy
Key word searches, using combinations of key words and Medi-
cal Subject Headings (or equivalent), were used across six 
concepts using the AND Boolean operator: (1) child; 
(2) mother/parent; (3) BMI/obesity; (4) nutrition/physical activ-
ity/sleep/parenting; (5) intervention/prevention; (6) randomised 
controlled trial (RCT)/quasi-randomised trials. Within each 
of the categories, keywords were combined using the “OR” 
Boolean operator. The search strategy was purposefully broad 
enough to capture any study which might have assessed 
weight-related measures in children under the age of two. 
The search strategy was initially developed in Embase® 
(see extended data36), appropriately tailored for use within the 
other databases, and piloted before final searches were run.
One reviewer (MH) searched the following databases from 
inception to 04 April 2019 using pre-specified search strategies: 
CINAHL Complete (EBSCOhost; 1994); Embase® (Elsevier; 
1980); MEDLINE (Ovid®; 1966); PsycINFO (Ovid®; 1978); 
PubMed (1996); The Cochrane library databases: The Cen-
tral Register of Controlled Trials; Database of Systematic 
Reviews; Database of Abstracts of Reviews of Effect (Wiley; 
1996). Conference proceedings and other grey literature were 
searched on: Open Grey (INIST-CNRS; 2011) and Web of 
Science™ (Thomson Reuters). ProQuest Dissertations & 
Theses Global, and ProQuest Dissertations & Theses – UK 
and Ireland, were used to identify eligible dissertation and 
thesis studies internationally. We also searched the Inter-
national Clinical Trials Registry Platform Search Portal, 
ClinicalTrials.gov, and the ISRCTN registry to identify any 
ongoing or unpublished research trials. Reference lists of 
previous systematic reviews on this topic were manually 
searched, as well as those of retrieved full texts.
Supplementary materials and trial registry protocols were also 
checked. No restrictions were applied to: language; date of 
publication; the length of follow-up of outcomes (given the 
diversity reported within systematic reviews to date); type 
of setting; mode of delivery. Records were de-duplicated 
in Endnote, imported into COVIDENCE and any remaining 
duplicates removed.
Study inclusion and exclusion criteria
Table 1 details the study inclusion and exclusion criteria. 
We included randomised controlled trials, including cluster- 
randomised controlled trials, or quasi-randomised trials 
comparing any behavioural intervention, delivered by health pro-
fessionals, with ‘usual care’/active comparator which aimed to 
prevent overweight/obesity in children under the age of two 
that were born at term. Studies had to report at least one infant/
child-related adiposity and/or weight outcome measure at 
follow-up, which could be immediately post-intervention, or 
at any time point thereafter); trials only reporting infant birth 
weight were excluded.
Study selection
MH and LT independently screened titles and abstracts against 
the inclusion criteria, and following the retrieval of full-texts, 
MH and LvR independently reviewed them for inclusion. 
Disagreements were resolved through discussion, with a third 
author (MB / CH / RL) where necessary.
Data extraction
All published papers and supplementary material related to 
the study (e.g. protocol papers and trial registry protocols, 
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reference to websites with working hyperlinks, long-term 
follow-up studies) were used alongside the included article 
for data extraction. Data were extracted by one author (MH) 
using a pre-piloted data extraction tool (see extended data36), 
with 20% double-checked by a second reviewer (HCW). Inter-
vention descriptions were extracted following the criteria 
outlined in the TIDieR reporting guidelines40. The external 
validity assessment tool previously developed by RL18,32 was 
used to assess the extent to which included studies/trials 
reported on elements that would aid decision-making around 
whether the findings of such studies/trials could be generalised 
to populations or settings beyond those in the original study21. 
This tool includes five main dimensions (defined in Table 2): 
1) reach and representativeness (individuals); 2) reach and rep-
resentativeness (settings); 3) implementation and adaptation 
(of intervention), which includes fidelity considerations; 
4) outcomes for decision makers; 5) maintenance and insti-
tutionalisation (i.e. the potential for implementation of the 
intervention in routine service delivery). Included studies 
were coded according to whether they met each criterion (yes, 
no, or not applicable). Initially, two authors (MH and RL) inde-
pendently assessed the external validity reporting of 20% 
of included studies. Any discrepancies were resolved through 
discussion, and then one author (MH) completed assessments 
of the remaining studies. We did not exclude any studies 
on the basis of the effectiveness and/or quality assessment.
Results
Electronic and hand searches identified 27,609 references (see 
Figure 1). Following duplicate removal and title and abstract 
screening, 230 references were selected for full text review. 
We identified 39 eligible studies with 46 unique intervention 
arms and a total of 180 eligible papers41–79. Five trials had more 
than one eligible intervention arm60,65,68,75,77.
Studies were mostly published from 2011 onwards (n=34), 
conducted in high-income countries (n=33), and targeted the 
period from birth to 2 years only (n=26). They focused on a 
Table 1. Study inclusion criteria.
Design Randomised, and quasi-randomised, controlled trials, including individual cluster randomised trials
Participants Studies which targeted pregnant women and/or parents (including mothers/fathers/carers/guardians) of healthy infants 
less than two years old and/or infants born at term gestation (37 to 42 weeks of gestation) and up to two years of age. 
○   No restrictions for sex, ethnicity, socio-economic group, or region, were applied.
○   Studies where children aged under two years were part of a family group receiving the intervention were included only if 
data could be extracted separately for these children
Intervention ○   Behavioural interventions designed to prevent obesity (by directly/explicitly focusing on childhood obesity prevention, 
or by indirectly focusing on childhood obesity-related risk factors) in infants (e.g. individual counselling, face-to-face 
sessions, audio-visual packages, support groups, online interventions/forums) delivered by health professionals 
antenatally and/or up to a child’s second birthday.
○   Behavioural interventions were defined as “those that require the active participation of a target group (e.g. patient, 
individual, health professional) in a programme delivered by a trained interventionist with the goal of changing health-
related behaviour”37.
○   Interventions targeting key risk factors for childhood obesity38, including: early rapid weight gain, infant feeding method, 
timing of introduction of solid foods, and gestational weight gain
○   Health professionals were defined according to the International Standard Classification of Occupations (ISCO)  
ISCO-0839. For the purposes of this review, research nurses, lactation consultants, psychologists, and social workers 
were also classified as health professionals
Comparator Participants who were not exposed to an intervention/wait-list control, or an active comparator, or who received ‘usual 
care’. ‘Usual care’ is defined as standard support and/or appointments without an obesity prevention focus
Outcomes Primary 
○  Infant/child body mass index (BMI) z score 
○   Additional anthropometric/growth-related: e.g. growth rates (weight gain, linear growth, and head growth, change in BMI 
z score), percent fat content, ponderal index, skin-fold thickness
Secondary (*intermediate behavioural outcomes) 
○   Diet-related*: e.g. breastfeeding initiation and duration (total and exclusive); dietary intake and quality; timing of 
introduction of solid food(s)
○  Feeding/eating behaviour-related*: e.g. responsive feeding practices
○  Physical activity-related*: e.g. physical activity, tummy time, play, screen time
○   Sedentary time/behaviour-related*: e.g. frequency/time spent: being inactive, doing specific low-energy behaviours 
such as screen time
○  Sleep* 
○  Environment-related*: e.g. outcomes related to the physical (e.g. food availability) and social environment
○  Cost effectiveness/costs of the intervention
Publications Trials reported only as abstracts were deemed eligible for inclusion if sufficient information was available from the report, or 
from contact with the authors, to fulfil the inclusion criteria
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Target population for generalizability Is the intended target population acknowledged/stated (at the individual level) 
for which the findings intend to be generalised to?
38/39 97
Method to recruit target population Was information provided about how the target population was recruited/
reached (e.g., radio, newspaper, TV, school meeting)?
30/39 77
Inclusion or exclusion criteria Were individual inclusion and exclusion criteria stated? 38/39 97
Enrolment rate Is the enrolment rate or data needed to calculate the enrolment rate among 
individuals reported? Proportion of people who are eligible for participation who 
actually enrol in the study
26/39 67
Recruitment rate Is the recruitment rate or data needed to calculate the recruitment rate among 
individuals reported? Proportion of potential participants (those invited or 
expressing interest) who actually enrol in the study
26/39 67
Representativeness of individuals Are there comparisons between individuals who participated versus either (1) 
those who declined to participate or (2) target population?
10/39 26
Participant characteristics Are all of the following reported: 
•Gender 
•Age 
•Any socioeconomic indicators (education, employment status, or income) 
•Participation by racial or ethnic minority groups
21/39 54
Reach and representativeness of settings
Target setting Is the target setting for intervention delivery stated (such as workplace, general 
practice, outpatient facilities, churches, etc.)?
35/38 92
Method to recruit setting Is information provided about how the site(s) within a given setting were 
recruited/reached to participate in delivering the intervention?
4/28 14
Inclusion or exclusion criteria Were inclusion and exclusion criteria for selection of sites within a given 
setting stated? In the case of single sites, were the characteristics of the site 
described?
6/28 21
Participation rate Is the participation level or data need to calculate the participation level among 
eligible sites reported (only applies to studies with more than one site)?
1/19 5
Representativeness of setting(s) Are there comparisons between site(s) participating in the intervention and 1) 
those that decline to participate or 2) the target setting?
1/28 4
Implementation and adaptation
Intervention characteristics Were the intervention components described? 38/39 97
Intervention adaptation Is information reported about how the study intervention is similar or different to 
original efficacy studies? 
Note: Only applicable to studies where an intervention is adapted from a 
previous trial
0/5 0
Time to deliver intervention 
described
Is the number and length of sessions or time required to deliver the intervention 
described?
24/37 65
Intervention delivery and exposure Was the extent to which individuals were exposed to the intervention 
described? (e.g. proportion of planned intervention sessions actually attended 
(dose); content delivered as specified; provider adherence to intervention plan)
24/37 65
Delivery agents: characteristics and 
training
Is information provided on who delivered the intervention, such as the type of 
professional, or the amount of experience, skill or training required to deliver the 
intervention?
37/39 95
Methods to recruit delivery agents Is information provided about how the delivery agents were identified/selected? 3/36 8
Delivery agents’ participation Is the participation level amongst delivery agents reported (% of delivery 
agents agreeing to participate)?
4/35 11
Fidelity assessment: treatment 
receipt
Is information reported about whether the program was received as intended? 
(e.g. degree to which the participants understood the intervention and/or ability 
to perform the intervention skills)
4/39 10
Mechanisms for intervention effects Was retrospective analysis conducted to identify the mediating variables 
through which the intervention achieved its effect?
2/39 5
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Outcomes that can be compared to 
standards
Are outcomes (at least one) reported in a way that can be compared to either 
clinical targets or public health goals?
36/39 92
Adverse consequences Does the article report whether they examined the occurrence of unintended 
consequences?
18/39 46
Effect moderators by participant 
characteristics
Are there any analyses of moderator effects by subgroups of participants 10/39 26
Effect moderator by delivery agent/
setting
Are there any analyses of moderator effects by delivery agents or settings 0/37 0
Dose response effect of intervention 
(sensitivity)
Are there sensitivity analyses to assess dose-response effects of the 
intervention?
1/39 3
Total costs of intervention Are total costs of the intervention presented? 6/39 15
Cost of intervention components If costs are presented, were the costs itemized by intervention components 
(e.g., personnel, equipment)?
4/6 67
Cost effectiveness If costs are presented, was there any analysis done to assess cost-
effectiveness or cost-benefit of the program or policy?
3/6 50
Maintenance / institutionalisation
Long term effects (at least 12 
months)3
Are data reported on longer term effects on health-related outcomes, at least 12 
months following program implementation, or environmental or policy change?
19/39 49
Institutionalization: sustainability / 
plans for sustainability
Are data reported on the sustainability (or reinvention or evolution) or plans for 
sustainability of the intervention?
4/39 10
Attrition Are data reported on the number of individuals dropping out and/or lost to 
follow up
38/39 97
Differential attrition (by condition or 
population sub-group)
Are data on attrition by condition or population sub-group reported? 35/39 90
Representativeness of completers/
dropouts
Did the study report statistically significant differences in those that dropped out 
of treatment and those that finished?
19/38 50
Acceptability of the intervention by 
stakeholders




1Laws et al. (adapted from Green et al.)
2Total = the no. of overall studies (n=39) minus the no. of studies reporting not applicable to the relevant element
3In RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance), long-term results of intervention are defined as a minimum of six months 
following the last contact; long-term is defined as a minimum of 12 months by Laws et al.
range of behaviours and outcomes, including: multiple infant 
behaviours (n=13); infant feeding: formula feeding / breast-
feeding / introduction to solids (n=10); maternal diet/physical 
activity/gestational weight gain (n=9); infant feeding: breast-
feeding only (n=8). Only 16 of the 46 interventions were clearly 
delivered as part of routine care, with a further two partly 
delivered as such. Details of intervention descriptions and 
outcomes are available as extended data36.
The assessment of the reporting of external validity elements 
of the 39 included studies is summarised in Table 2, with a 
summary by study available as extended data36. Inter-rater reli-
ability, using percent agreement, was high (88.2%). Full details 
of the these assessments, including supporting statements for 
each study, are available as extended data36. The number and 
percentage of studies reporting all elements of each dimension 
of external validity are outlined in Table 3.
Reach and representativeness of participants
Only 15% of studies reported on all elements of this exter-
nal validity dimension (Table 3). While almost all studies 
outlined the target population for generalizability (97%) and 
inclusion and exclusion criteria (97%), less reported the recruit-
ment method (77%), enrolment rate (67%), and recruitment 
rate (67%) (Table 2). Just over half (54%) reported all of the 
specified participant characteristics - gender, age, any socio-
economic indicators (education, employment status, or income 
– and participation by racial or ethnic minority groups. 
Only one in four studies included comparisons between 
individuals who participated versus either (1) those who 
declined to participate or (2) target population.
Reach and representativeness of settings
One in four studies reported on all elements of ‘reach and 
representativeness of settings’ (Table 3). Almost all studies 
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Figure 1. PRISMA flow diagram.
Table 3. Number and percentage of studies reporting all elements of each dimension of external validity1.
External validity dimension No./Total2 % Studies
Reach and representativeness of 
participants 
6/39 15 NOURISH, PRIMROSE, Baby Milk Trial, INSIGHT, BLISS, POI
Reach and representativeness of 
settings
9/38 24 ProKind, Baby Milk Trial, Minding the Baby, SLIMTIME, INSIGHT, BLISS, 
POI, Healthy MOMS, Healthy Beginnings
Implementation and adaptation 0/39 0 None
Outcomes for decision making 0/39 0 None
Maintenance / institutionalisation 1/39 3 INSIGHT
Notes:
1Laws et al. (adapted from Green et al.)
2No. taken as sum of no. of studies reporting yes or not applicable to each of the element. Total excludes any studies for which the external 
validity criterion was not applicable (e.g. Grow2Gether was a social media intervention therefore ‘research and representativeness of settings’ 
criterion was not applicable).
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provided details of the target setting for intervention deliv-
ery (92%); however, the remaining criteria were poorly 
described: inclusion and exclusion criteria (21%), how set-
tings were recruited/reached to participate in delivering the 
intervention (14%) (Table 2). Only one study reported the par-
ticipation level among eligible sites (5%); this was also the 
case for the representativeness of setting(s) (4%).
Implementation and adaptation
No studies reported on all elements of this external validity 
dimension (Table 3). Most studies described the intervention 
characteristics (97%) and the characteristics and training of 
delivery agents (95%). Less described the time to deliver the 
intervention (65%), and intervention delivery and exposure 
(65%) (Table 2). Delivery agents’ participation (11%), fidelity 
assessment: treatment receipt (10%), methods to recruit 
delivery agents (8%), and mechanisms for intervention 
effects (5%) were very poorly reported. Only five of the 
studies tested an intervention that was adapted from a previous 
trial - none reported on how the study intervention was 
similar or different to original efficacy studies.
Outcomes for decision making
No studies reported on all elements of ‘outcomes for 
decision making’ (Table 3). Almost all studies reported out-
comes in a way that could be compared to either clinical 
targets or public health goals (92%) (Table 2). Less than half of 
studies reported whether they examined the occurrence of 
unintended consequences (46%). Only six studies reported the 
total costs of the intervention (15%); of these, four studies 
reported the cost of intervention components (67%), and three 
examined cost effectiveness (50%). Ten studies (26%) exam-
ined effect moderators by participant characteristics; however, 
none reported effect moderators by delivery agent/setting. 
Only one study (3%) reported a sensitivity analyses to assess 
dose-response effects of the intervention.
Maintenance / institutionalisation
Only one study – INSIGHT – reported on all elements of main-
tenance / institutionalisation (Table 3). Almost all studies 
(97%) reported on the number of individuals dropping out 
and/or lost to follow up (Table 2). Data on attrition by con-
dition or population sub-group reported by 90% of studies 
(Note: we took condition to mean by intervention or control 
group). Only 50% of studies addressed the representativeness 
of completers/dropouts. Half of studies (49%) reported data 
on longer term effects on health-related outcomes (at least 
12 months following program implementation, or environmental 
or policy change). Only 10% of studies reported on the sustain-
ability (or reinvention or evolution) or plans for sustainability 
of the intervention. Only 36% reported on the acceptability 
of the intervention by stakeholders.
Discussion/ Conclusion
Early life interventions delivered by health professionals have 
the potential to influence important health behaviours, in addi-
tion to child weight. Understanding the reporting of external 
validity elements of such interventions is vital to address their 
potential for translation and scalability, as well as replication 
efforts. In this systematic review we identified 39 studies, 
representing 46 interventions. External validity elements that 
were generally well reported included target populations and 
settings, participant inclusion and exclusion criteria, interven-
tion characteristics, delivery agents, outcomes, and attrition. 
Similar to other reviews of childhood obesity interventions17,18, 
however, we identified important gaps in the reporting of exter-
nal validity elements within studies, and factors that could 
enhance translation and scale-up of interventions across all five 
external validity dimensions. External validity elements that 
were poorly reported included: representativeness of individu-
als and settings, treatment receipt, intervention mechanisms and 
moderators, cost effectiveness, and intervention sustainability 
and acceptability.
Key gaps in informing the translation and scalability of health 
professional-delivered early life obesity prevention interven-
tions were identified in this review. These included understanding 
the representativeness of settings, and whether these settings 
and delivery agents could be engaged to deliver these types of 
interventions in a sustained way, in a way that is acceptable 
to those involved. This is especially important given that only 
16 of the 46 interventions (35%) in this review were clearly 
delivered as part of routine care, with a further two partly 
delivered as such, i.e. contacts as part of routine care but addi-
tional contacts also (Starting Early78 and STRIP79). The focus 
of the majority of studies was on establishing efficacy rather 
than effectiveness or how such interventions could be scaled 
up and translated into routine practice. This may account for 
the poor reporting of external validity in relation to settings 
and delivery agents. It could be argued that efficacy trials 
should not be held to the same level of accountability regard-
ing reporting of external validity elements. Such information 
however is important regardless of trial type, not only to inform 
generalisability, but also to enhance understanding of the active 
ingredients of interventions and core components to retain 
in effectiveness trials or the scale-up of interventions.
Reporting of external validity elements considered impor-
tant to inform decision makers was generally poor also. This 
included cost and cost-effectiveness measures, and an under-
standing of the intervention mechanisms and dose-response 
effects. While most interventions that are scaled up need to be 
adapted to fit the delivery context, knowing information about 
dose-response and the mechanism of intervention effects is 
essential in informing adaptions so that effectiveness of the inter-
vention is not lost. The recent systematic review by McCrabb and 
colleagues highlights the decreased intervention effects when 
obesity interventions are scaled up – they found that effects on 
weight status, physical activity/sedentary behaviour, and nutri-
tion reported in scaled-up interventions were typically 75% 
or less of the effects reported in pre–scale-up efficacy trials9. 
Reporting of fidelity components in our review was also varied 
– training (95%), delivery (65%), and receipt (10%). This has 
been noted in other childhood obesity-related reviews80,81, and 
has important implications for the interpretation, as well as the 
generalisability, of study findings.
Despite calls for greater attention to external validity for 
almost 40 years now16,82–84, we noted that problems with atten-
tion to generalisability persist. Only one trial within this review, 
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the INSIGHT trial56, reported on all elements of the exter-
nal validity assessment tool developed by RL18,32. Earlier this 
year, Huebschmann and colleagues made a further call for 
increased attention to external validity82. For trialists, there is a 
tension between internal validity and external validity, with 
preference historically for ensuring the former and minimising 
the risk of bias, at the expense of generalisability and appli-
cability to real-world settings. Standard reporting guidelines 
such as the CONSORT statement for the reporting of rand-
omized controlled trials85, the CONSORT extension for cluster 
trials86 and the CONSORT extension for pragmatic trials87 
traditionally focus on internal validity elements, with limited 
focus and guidance around external validity. The TIDieR report-
ing guidelines for intervention description and replication 
somewhat address this gap40.
We acknowledge the challenging context in which triallists 
work and that there are many positive activities in this area. We 
have a number of suggestions for moving work in this area 
forward nevertheless. Triallists could plan their interventions 
with scalability and sustainability in mind, giving due consid-
eration to the type of trial conducted as well as the intervention 
characteristics. Few researchers plan for the sustainability of their 
interventions88. The aforementioned reporting guidelines 
can be used in combination to report on study findings, with 
additional materials published to enhance external validity assess-
ment, including protocols and more detailed information made 
accessible via supplementary materials or open access reposi-
tories. Researchers could also use models such as RE-AIM 
to guide reporting of external validity elements. If research-
ers used RE-AIM as a planning tool when designing their 
intervention and evaluation, this might also overcome some 
of the difficulties in reporting on RE-AIM components 
relevant to external validity. Glasgow and Estabrooks note 
the challenges in comprehensively reporting on all RE-AIM 
dimensions within community and clinical settings with lim-
ited resources, however, highlighting that even well-funded NIH 
grants and published research studies, stating use of the RE-AIM 
framework, only employ it partially, and inconsistently when 
they do so89. Inconsistencies in the degree to which authors 
report each RE-AIM dimension in its entirety as well as inaccu-
racies in reporting elements within each dimension have been 
highlighted by other authors also22,90. Further work is needed 
with researchers to embed such frameworks appropriately. As 
mentioned above, increasing the availability of protocols and 
more detailed information via supplementary materials or open 
access repositories is one such step. Research to understand 
the facilitators and barriers to reporting elements of external 
validity, as well as work with stakeholders to prioritise the most 
important elements/dimensions of external validity reporting 
would be useful to enhance work in this area. A recently 
published tool on assessment of scalability contains several 
elements relevant to external validity assessment91. These include: 
costs and cost effectiveness, intervention characteristics, informa-
tion on delivery agents, participation rate of settings, outcomes 
that can be compared to standards, effect moderators, adverse 
consequences, and acceptability. Such elements should be 
prioritised by researchers in planning studies and reporting 
findings.
Funding bodies, review panels, journals/journal editorial boards, 
and policymakers could also take action to promote the inte-
gration of external validity considerations into the funding, 
design, conduct, reporting, synthesis and translation of 
research19,82,84,92. This need not be at the expense of internal valid-
ity, and can help facilitate credible research and knowledge 
translation82,92. The inclusion of a PRECIS-2 graphic when 
proposing or reporting on a study can also be undertaken to 
enable the assessment of external validity82.
Strengths and limitations
The strengths of this work are the use of a comprehensive and 
rigorous methodology, including a broad search strategy and 
range of databases, no language restrictions, and the screen-
ing of trials and extraction of data by two independent review 
authors. A number of limitations, however, must be noted. 
While we included journal articles, protocols, grey literature and 
supplementary materials, it is possible that researchers of the 
reviewed studies may have collected some of the informa-
tion required to complete the external validity assessment but 
did not report it in the articles published to date. Furthermore, 
the external validity tool only codes items as present, absent, 
or not applicable. The extent, or quality, to which the stud-
ies report on the various external validity elements, e.g. fidelity, 
is not assessed; this may result in an over-estimation of the 
reporting quality of some studies. While it is not necessary for 
all studies to be strong on all of the external validity criterion, 
researchers, decision-makers and others could use this informa-
tion, if provided, to make judgments as to the applicability or 
generalisability of a study or review16.
Conclusion
This review examined the reporting of external validity ele-
ments within 39 studies encompassing 46 early-life health 
professional-delivered interventions. While such interventions 
have the potential to influence important health behaviours, 
in addition to child weight, we identified important gaps in 
the reporting of external validity elements within studies, and 
factors that could enhance translation and scale-up of inter-
ventions across all five external validity dimensions. External 
validity elements that were poorly described included: rep-
resentativeness of individuals and settings, treatment receipt, 
intervention mechanisms and moderators, cost effectiveness, 
and intervention sustainability and acceptability. More emphasis 
is needed on research designs that consider generalisability, 
and the reporting of external validity elements in early life 
childhood obesity prevention interventions.
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